The top medtech stories of early 2017

Donald Trump

[Image courtesy of the White House]

Donald Trump

Like him or hate him, President Donald Trump has the medical device industry’s attention. For the most part, the industry’s top executives have sounded positive during earnings calls with analysts. Medtech insiders are especially optimistic that the much-hated medical device excise tax will soon be dead for good and that Trump and his fellow Republicans will get regulators out of the way of innovation.

Trump’s unpredictable style, however, appears to be generating a great deal of uncertainty. As of March 24, Republican leaders had pulled the American Health Care Act – the plan to repeal and replace the Affordable Care Act – as their own rank and file in the House revolted against the bill. Trump had threatened that the chance to repeal Obamacare would vanish if the proposal did not move forward. “We just pulled it,” Trump told The Washington Post.

What is going to happen with Medicare? Will Congress do something about drug prices? How protectionist will Trump’s trade policies be?  Will deregulation at FDA and implementation of the 21st Century Cures Act be confusion-free?

And this, perhaps, is the most important question: What else is going to happen?


DeviceTalks West: Expertise you need to know

textadimage Medical device suppliers are light years away from the days when they merely filled orders to spec for medtech OEMs – as a visit to the upcoming DeviceTalks West will quickly confirm.

From incorporating steerability into catheters to getting validation and testing done right, the companies serving the medical device industry have become specialized experts in their own right.

Read on to discover five example of medical device expertise to be had at DeviceTalks West, which runs Dec. 11–12 in Orange County, Calif.

Pages: 1 2 3 4 5 6

Speak Your Mind